| Rachel Frederick, MD | |
|
1500 E. Medical Center Dr., B1-380 Taubman Center, Ann Arbor, MI 48109-5305 | |
| (734) 763-7919 | |
| (734) 763-9298 |
| Full Name | Rachel Frederick |
|---|---|
| Gender | Female |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 1500 E. Medical Center Dr., Ann Arbor, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386266013 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 4301509631 (Michigan) | Secondary |
| 390200000X | Student In An Organized Health Care Education/training Program | (Michigan) | Primary |
| Entity Name | Hawk Emergency Group, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073295135 PECOS PAC ID: 6800241050 Enrollment ID: O20231009002612 |
News Archive
Massachusetts General Hospital investigators may have uncovered a novel mechanism behind the ability of obesity to promote cancer progression. In their report published online in the journal Clinical Cancer Research, the research team describes finding an association between obesity and an overabundance of a factor called PlGF (placental growth factor) and that PlGF's binding to its receptor VEGFR-1, which is expressed on immune cells within tumors, promotes tumor progression.
Centene Corporation today announced its financial results for the quarter ended March 31, 2011.
A team of researchers from the Department of Energy's Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.
Breast cancer tumors take numerous paths to resist the targeted drug Herceptin, but a single roadblock at a crucial crossroads may restore a tumor's vulnerability to treatment, scientists at The University of Texas MD Anderson Cancer Center report on line at Nature Medicine.
Lives of soldiers and others injured in remote locations could be saved with a cell-free protein synthesis system developed at the Department of Energy's Oak Ridge National Laboratory.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Frederick, MD 1500 E. Medical Center Dr., B1-380 Taubman Center, Ann Arbor, MI 48109-5305 Ph: (734) 763-7919 | Rachel Frederick, MD 1500 E. Medical Center Dr., B1-380 Taubman Center, Ann Arbor, MI 48109-5305 Ph: (734) 763-7919 |
News Archive
Massachusetts General Hospital investigators may have uncovered a novel mechanism behind the ability of obesity to promote cancer progression. In their report published online in the journal Clinical Cancer Research, the research team describes finding an association between obesity and an overabundance of a factor called PlGF (placental growth factor) and that PlGF's binding to its receptor VEGFR-1, which is expressed on immune cells within tumors, promotes tumor progression.
Centene Corporation today announced its financial results for the quarter ended March 31, 2011.
A team of researchers from the Department of Energy's Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.
Breast cancer tumors take numerous paths to resist the targeted drug Herceptin, but a single roadblock at a crucial crossroads may restore a tumor's vulnerability to treatment, scientists at The University of Texas MD Anderson Cancer Center report on line at Nature Medicine.
Lives of soldiers and others injured in remote locations could be saved with a cell-free protein synthesis system developed at the Department of Energy's Oak Ridge National Laboratory.
› Verified 7 days ago